Reduced 5-HT2A receptor binding in patients with mild cognitive impairment
- 4 June 2007
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 29 (12) , 1830-1838
- https://doi.org/10.1016/j.neurobiolaging.2007.04.011
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Neuropathological Study of the Dorsal Raphe Nuclei in Late-Life Depression and Alzheimer’s Disease With and Without DepressionAmerican Journal of Psychiatry, 2004
- Role of the Serotonin 5-HT2AReceptor in LearningLearning & Memory, 2003
- Quantification of 5-HT2A Receptors in the Human Brain Using [18F]Altanserin-PET and the Bolus/Infusion ApproachJournal of Cerebral Blood Flow & Metabolism, 2003
- β-Amyloid(1-42)-Induced Cholinergic Lesions in Rat Nucleus Basalis Bidirectionally Modulate Serotonergic Innervation of the Basal Forebrain and Cerebral CortexNeurobiology of Disease, 2001
- Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography studyAnnals of Neurology, 2000
- Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain SecretionJournal of Biological Chemistry, 1996
- The Neuropsychiatric InventoryNeurology, 1994
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer typeNeuroscience Letters, 1984